| Style | Citing Format |
|---|---|
| MLA | Khorasanizadeh M, Eskian M, Rezaei N. "Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma." Acta Medica Iranica, vol. 55, no. 5, 2017, pp. 352-353. |
| APA | Khorasanizadeh M, Eskian M, Rezaei N (2017). Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma. Acta Medica Iranica, 55(5), 352-353. |
| Chicago | Khorasanizadeh M, Eskian M, Rezaei N. "Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma." Acta Medica Iranica 55, no. 5 (2017): 352-353. |
| Harvard | Khorasanizadeh M, Eskian M, Rezaei N (2017) 'Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma', Acta Medica Iranica, 55(5), pp. 352-353. |
| Vancouver | Khorasanizadeh M, Eskian M, Rezaei N. Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma. Acta Medica Iranica. 2017;55(5):352-353. |
| BibTex | @article{ author = {Khorasanizadeh M and Eskian M and Rezaei N}, title = {Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma}, journal = {Acta Medica Iranica}, volume = {55}, number = {5}, pages = {352-353}, year = {2017} } |
| RIS | TY - JOUR AU - Khorasanizadeh M AU - Eskian M AU - Rezaei N TI - Reductions in Eosinophil Biomarkers by Benralizumab in Patients With Asthma JO - Acta Medica Iranica VL - 55 IS - 5 SP - 352 EP - 353 PY - 2017 ER - |